BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 29198440)

  • 1. Fanconi Anemia Signaling and Cancer.
    Nepal M; Che R; Zhang J; Ma C; Fei P
    Trends Cancer; 2017 Dec; 3(12):840-856. PubMed ID: 29198440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal Point of Fanconi Anemia Signaling.
    Zhan S; Siu J; Wang Z; Yu H; Bezabeh T; Deng Y; Du W; Fei P
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fanconi anemia pathway--the way of DNA interstrand cross-link repair.
    Yao CJ; Du W; Zhang Q; Zhang F; Zeng F; Chen FP
    Pharmazie; 2013 Jan; 68(1):5-11. PubMed ID: 23444773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifaceted Fanconi Anemia Signaling.
    Che R; Zhang J; Nepal M; Han B; Fei P
    Trends Genet; 2018 Mar; 34(3):171-183. PubMed ID: 29254745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A defined role for multiple Fanconi anemia gene products in DNA-damage-associated ubiquitination.
    Tan W; Deans AJ
    Exp Hematol; 2017 Jun; 50():27-32. PubMed ID: 28315701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA damage response and cancer therapeutics through the lens of the Fanconi Anemia DNA repair pathway.
    Bhattacharjee S; Nandi S
    Cell Commun Signal; 2017 Oct; 15(1):41. PubMed ID: 29017571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FANCD2 and DNA Damage.
    Nepal M; Che R; Ma C; Zhang J; Fei P
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28825622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the understanding of the Fanconi anemia tumor suppressor pathway.
    Pickering A; Zhang J; Panneerselvam J; Fei P
    Cancer Biol Ther; 2013 Dec; 14(12):1089-91. PubMed ID: 24025411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA interstrand cross-link repair: understanding role of Fanconi anemia pathway and therapeutic implications.
    Shukla P; Solanki A; Ghosh K; Vundinti BR
    Eur J Haematol; 2013 Nov; 91(5):381-93. PubMed ID: 23859405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins.
    Wang W
    Nat Rev Genet; 2007 Oct; 8(10):735-48. PubMed ID: 17768402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathogenesis of Fanconi anemia.
    Collins N; Kupfer GM
    Int J Hematol; 2005 Oct; 82(3):176-83. PubMed ID: 16207587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update of the human and mouse Fanconi anemia genes.
    Dong H; Nebert DW; Bruford EA; Thompson DC; Joenje H; Vasiliou V
    Hum Genomics; 2015 Nov; 9():32. PubMed ID: 26596371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF-α signaling in Fanconi anemia.
    Du W; Erden O; Pang Q
    Blood Cells Mol Dis; 2014 Jan; 52(1):2-11. PubMed ID: 23890415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathogenesis of Fanconi anemia: recent progress.
    Taniguchi T; D'Andrea AD
    Blood; 2006 Jun; 107(11):4223-33. PubMed ID: 16493006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNF4-mediated polyubiquitination regulates the Fanconi anemia/BRCA pathway.
    Xie J; Kim H; Moreau LA; Puhalla S; Garber J; Al Abo M; Takeda S; D'Andrea AD
    J Clin Invest; 2015 Apr; 125(4):1523-32. PubMed ID: 25751062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the FA pathway mediated by phosphorylation and ubiquitination.
    Ishiai M; Sato K; Tomida J; Kitao H; Kurumizaka H; Takata M
    Mutat Res; 2017 Oct; 803-805():89-95. PubMed ID: 28552166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dedicated to the core: understanding the Fanconi anemia complex.
    Gurtan AM; D'Andrea AD
    DNA Repair (Amst); 2006 Sep; 5(9-10):1119-25. PubMed ID: 16784902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent discoveries in the molecular pathogenesis of the inherited bone marrow failure syndrome Fanconi anemia.
    Mamrak NE; Shimamura A; Howlett NG
    Blood Rev; 2017 May; 31(3):93-99. PubMed ID: 27760710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated.
    Kennedy RD; Chen CC; Stuckert P; Archila EM; De la Vega MA; Moreau LA; Shimamura A; D'Andrea AD
    J Clin Invest; 2007 May; 117(5):1440-9. PubMed ID: 17431503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging functions of Fanconi anemia genes in replication fork protection pathways.
    Kolinjivadi AM; Crismani W; Ngeow J
    Hum Mol Genet; 2020 Oct; 29(R2):R158-R164. PubMed ID: 32420592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.